302 related articles for article (PubMed ID: 33545740)
1. Clinical advances in targeting epigenetics for cancer therapy.
Feng S; De Carvalho DD
FEBS J; 2022 Mar; 289(5):1214-1239. PubMed ID: 33545740
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of chromatin: status and opportunities.
Siklos M; Kubicek S
FEBS J; 2022 Mar; 289(5):1276-1301. PubMed ID: 33982887
[TBL] [Abstract][Full Text] [Related]
3. Cancer epigenetics: promises and pitfalls for cancer therapy.
Skourti E; Dhillon P
FEBS J; 2022 Mar; 289(5):1156-1159. PubMed ID: 35233949
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
Morrison AJ
FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
6. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors.
Kumar A; Emdad L; Fisher PB; Das SK
Adv Cancer Res; 2023; 158():73-161. PubMed ID: 36990539
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Therapies and Potential Drugs for Treating Human Cancer.
Lin SQ; Li X
Curr Drug Targets; 2020; 21(11):1068-1083. PubMed ID: 32209040
[TBL] [Abstract][Full Text] [Related]
8. Advances in epigenetic therapeutics with focus on solid tumors.
Jin N; George TL; Otterson GA; Verschraegen C; Wen H; Carbone D; Herman J; Bertino EM; He K
Clin Epigenetics; 2021 Apr; 13(1):83. PubMed ID: 33879235
[TBL] [Abstract][Full Text] [Related]
9. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
Cao J; Yan Q
Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in Personalized Management of Lung Cancer.
Ahmad A
Adv Exp Med Biol; 2016; 890():111-22. PubMed ID: 26703801
[TBL] [Abstract][Full Text] [Related]
11. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment.
Shirbhate E; Singh V; Jahoriya V; Mishra A; Veerasamy R; Tiwari AK; Rajak H
Eur J Med Chem; 2024 Jan; 263():115938. PubMed ID: 37989059
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics in cancer: Fundamentals and Beyond.
Biswas S; Rao CM
Pharmacol Ther; 2017 May; 173():118-134. PubMed ID: 28188812
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges.
Noberini R; Robusti G; Bonaldi T
FEBS J; 2022 Mar; 289(5):1191-1213. PubMed ID: 33415821
[TBL] [Abstract][Full Text] [Related]
15. Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy.
Duan YC; Zhang SJ; Shi XJ; Jin LF; Yu T; Song Y; Guan YY
Eur J Med Chem; 2021 Oct; 222():113588. PubMed ID: 34107385
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets for epigenetic therapy of cancer.
Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
Curr Pharm Biotechnol; 2009 Feb; 10(2):161-5. PubMed ID: 19199948
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic drugs against cancer: an evolving landscape.
Di Costanzo A; Del Gaudio N; Migliaccio A; Altucci L
Arch Toxicol; 2014 Sep; 88(9):1651-68. PubMed ID: 25085708
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review.
Saito Y; Saito H; Liang G; Friedman JM
Clin Rev Allergy Immunol; 2014 Oct; 47(2):128-35. PubMed ID: 24362548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
